Maxdata develops healthcare software solutions (Clinidata® software) for 4 decades, having a strong presence in the largest Portuguese hospitals in different areas and laboratories, namely, electronic requisition, clinical pathology, anatomic pathology, immunohematology (blood banking), epidemiologic surveillance (Healthcare Associated Infections) and responsability terms management. Clinidata® software is also present in a significative amount of laboratories across 3 continents, including reference laboratories integrated in international groups.
Maxdata has been a market leader since its inception, which is due mainly to the excellence of its products and services, both cyclically improved through continuous innovation. This innovation is made possible by the know-how the company has accumulated, and by the diverse background of its collaborators, almost all having university degrees at different levels: bachelor’s, master’s and PhD.
The focus on internationalization has intensified in recent years and is one of its most important strategic objectives. For this reason, Maxdata is currently re-engineering its products, adapting them to modern computing paradigms such as cloud computing and to many features that have been emerging in the new era of Web 2.0. The goal is to provide innovative and updated solutions, which will offer greater flexibility, scalability, security and economic efficiency.
The need to meet the quality requirements of international markets, which will soon apply to the Portuguese market, led Maxdata to become the first Portuguese company operating in the healthcare area certified according to the ISO 20000 international standard.
Maxdata is also a solid partner with sustained rates of growth throughout its history. Such performance has been awarded by IAPMEI (a Portuguese governement Institute for the Support of Small and Medium-sized Enterprises and Innovation), which distinguished Maxdata with the status of SME Leader (PME Líder) in 2009-2016 and SME Excellence (PME Excelência) in 2010, 2011, 2014 and 2016.